Mednax's CEO Discusses Q2 2012 Results - Earnings Call Transcript

Mednax, Inc. (MD)

Q2 2012 Earnings Call

July 31, 2012 10:00 a.m. ET


David Parker - Vice President, Investor Relations

Roger J. Medel - Chief Executive Officer

Vivian Lopez-Blanco - Chief Financial Officer


Ryan Daniels - William Blair & Company

Kevin Ellich - Piper Jaffray Companies

Kevin Fischbeck – Bank of America Merrill Lynch

John Ransom - Raymond James

Gary Taylor – Citigroup

Ralph Giacobbe - Credit Suisse

Brooks O'Neil - Dougherty & Company

Kevin Campbell - Avondale Partners

Robert Mains - Stifel Nicolaus & Company, Inc.



Ladies and gentlemen, thank you for standing by and welcome to the Mednax Second Quarter Earnings Conference Call. (Operator instructions) As a reminder, this teleconference is being recorded.

Now, at this time I will turn the conference call over to your hose, Vice President of Investor Relations, Mr. David Parker. Please go ahead, sir.

David Parker

Thank you, Tony, and, as he indicated, welcome to Mednax's 2012 second quarter earnings call.

Certain statements and information during this conference call may be deemed to be forward-looking statements within the meaning of the Federal Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on assumptions and assessments made by Mednax's management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements made during this call are made as of today and Mednax undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise.

If you liked this article you might like

Why the Boardroom Doesn't Need Ivy League Degrees

Mednax: Solid Growth at a Good Price

Analysts' Actions -- Kimberly-Clark, IberiaBank, Ionis Pharma, Actuant and More

How to Invest in Your Favorite MD